JournalsHub
.online
Find My Journal
IA

Ilaria Attili

Ripamonti IT

ORCID 0000-0003-1333-6622
129
Publications
2,201
Citations
27
H-Index
46
i10-Index
3.62
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

129 total

Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options PDF

Francesco Petrella, Stefania Rizzo, Ilaria Attili, Antonio Passaro, Thomas Zilli et al. - Current Oncology, 2023
Cited by 88 OpenAlex

Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours

Stefania Crucitta, Federico Cucchiara, Ron H.J. Mathijssen, Joaquı́n Mateo, Agnes Jager et al. - Cancer Treatment Reviews, 2022
Cited by 87 OpenAlex

Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer PDF

Giulia Pasello, Alberto Pavan, Ilaria Attili, Alberto Bortolami, Laura Bonanno et al. - Cancer Treatment Reviews, 2020
Cited by 134 OpenAlex

Testing for COVID-19 in lung cancer patients PDF

Antonio Passaro, Solange Peters, Tony Mok, Ilaria Attili, Tetsuya Mitsudomi et al. - Annals of Oncology, 2020
Cited by 74 OpenAlex

Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published data

Antonio Passaro, Ilaria Attili, Stefania Morganti, Ester Del Signore, Letizia Gianoncelli et al. - Cancer Treatment Reviews, 2020
Cited by 71 OpenAlex

Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

Alberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, Ilaria Attili, Paola Del Bianco et al. - The Oncologist, 2019
Cited by 226 OpenAlex

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges PDF

Alberto Pavan, Ilaria Attili, Giulia Pasello, Valentina Guarneri, Pierfranco Conté et al. - Journal for ImmunoTherapy of Cancer, 2019
Cited by 95 OpenAlex

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

Laura Bonanno, Alberto Pavan, Maria Vittoria Dieci, Elisabetta Di Liso, Marco Schiavon et al. - European Journal of Cancer, 2018
Cited by 113 OpenAlex

Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis PDF

Niki Karachaliou, Imane Chaib, Andrés F. Cardona, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht et al. - EBioMedicine, 2018
Cited by 77 OpenAlex

Research Topics

Lung Cancer Treatments and Mutations (93) Cancer Immunotherapy and Biomarkers (62) Lung Cancer Research Studies (30) Cancer Genomics and Diagnostics (22) Cancer Mechanisms and Therapy (19)

Affiliations

University of Padua
IT 2024 - 2017
University of Milan
IT 2024 - 2024
Istituto Oncologico Veneto
IT 2024 - 2017
Ripamonti
IT 2025 - 2023
USP Institut Universitari Dexeus
ES 2020 - 2018

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now